bluebird bio executed a 1-for-20 reverse stock split on December 12, 2024, effective at 5:00 p.m. Eastern Time. The company's common stock began trading on a split-adjusted basis on The Nasdaq Global Select Market on December 13, 2024, under the existing symbol "BLUE". The new CUSIP number for the common stock is 09609G 209.The reverse split was approved by stockholders on December 4, 2024, with the board selecting the 1-for-20 ratio from a range of 1-for-15 to 1-for-20. Every 20 shares of issued and outstanding common stock were automatically converted into one share. The number of authorized shares and par value remain unchanged. No fractional shares will be issued; stockholders entitled to fractional shares will receive cash payments instead.The company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect this change. This action may impact the company's future results, performance, or achievements, as noted in the forward-looking statements section of the announcement.

bluebird bio executed a 1-for-20 reverse stock split on December 12, 2024, effective at 5:00 p.m. Eastern Time. The company's common stock began trading on a split-adjusted basis on The Nasdaq Global Select Market on December 13, 2024, under the existing symbol "BLUE". The new CUSIP number for the common stock is 09609G 209.The reverse split was approved by stockholders on December 4, 2024, with the board selecting the 1-for-20 ratio from a range of 1-for-15 to 1-for-20. Every 20 shares of issued and outstanding common stock were automatically converted into one share. The number of authorized shares and par value remain unchanged. No fractional shares will be issued; stockholders entitled to fractional shares will receive cash payments instead.The company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect this change. This action may impact the company's future results, performance, or achievements, as noted in the forward-looking statements section of the announcement.